[The efficacy and safety of tiotropium/olodaterol fixed-dose combination in Chinese patients with chronic obstructive pulmonary disease: a pooled subgroup analysis of TONADO 1+2].

Chunxue Bai、Yan Tang、Jian‐Bao Xin、Yali Li、Zhikui Li、Jian Kang、Jianan Huang、Wei Xiao

2019PubMedMedicine被引 3

摘要

Compared with tiotropium or olodaterol, tiotropium/olodaterol in Chinese patients provided significant improvement in lung function and quality of life, and the safety profiles were similar.

引用本文（GB/T 7714）

Chunxue Bai, Yan Tang, Jian‐Bao Xin, 等. [The efficacy and safety of tiotropium/olodaterol fixed-dose combination in Chinese patients with chronic obstructive pulmonary disease: a pooled subgroup analysis of TONADO 1+2].[J]. PubMed, 2019.

引文网络

参考文献与被引分析加载中…

DOI：https://doi.org/10.3760/cma.j.issn.1001-0939.2019.11.010

本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。